Ketamine Is Noninferior to ECT for Nonpsychotic Treatment-resistant Major Depression
Amit Anand, MD, director of Psychiatry Translational Clinical Trials at Brigham and Women’s Hospital, conducted ELEKT-D, a pragmatic comparative-effectiveness trial of ketamine and ECT for nonpsychotic treatment-resistant major depression.
Read More...